CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 140 filers reported holding CLOVIS ONCOLOGY INC in Q1 2016. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $479 | -99.9% | 10,050 | +0.5% | 0.01% | +8.3% |
| Q3 2022 | $477,000 | +23750.0% | 10,000 | +2757.1% | 0.01% | – |
| Q2 2021 | $2,000 | 0.0% | 350 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | – | 350 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q3 2019 | $1,000 | -75.0% | 190 | -24.0% | 0.00% | – |
| Q4 2018 | $4,000 | -85.2% | 250 | -37.5% | 0.00% | -100.0% |
| Q1 2018 | $27,000 | 0.0% | 400 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $27,000 | -73.8% | 400 | -68.0% | 0.00% | -75.0% |
| Q3 2017 | $103,000 | -22.0% | 1,250 | -11.0% | 0.00% | -33.3% |
| Q2 2017 | $132,000 | -33.3% | 1,405 | -54.8% | 0.01% | -33.3% |
| Q1 2017 | $198,000 | +9.4% | 3,110 | -23.7% | 0.01% | 0.0% |
| Q4 2016 | $181,000 | -42.2% | 4,075 | -53.0% | 0.01% | -43.8% |
| Q3 2016 | $313,000 | +281.7% | 8,675 | +44.6% | 0.02% | +220.0% |
| Q2 2016 | $82,000 | +86.4% | 6,000 | +380.0% | 0.01% | +66.7% |
| Q4 2015 | $44,000 | – | 1,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $45,630,648,000 | 43.63% |
| EcoR1 Capital, LLC | 384,348 | $21,523,000 | 10.89% |
| Palo Alto Investors LP | 2,102,857 | $117,760,000 | 6.91% |
| NEA Management Company, LLC | 2,279,781 | $127,668,000 | 6.19% |
| Redmile Group, LLC | 721,632 | $40,411,000 | 4.40% |
| Opaleye Management Inc. | 140,000 | $7,840,000 | 3.96% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 790,555 | $44,271,000 | 2.63% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 339,327 | $19,002,000 | 2.31% |
| PFM Health Sciences, LP | 1,725,126 | $96,607,000 | 2.26% |
| HARBOURVEST PARTNERS LLC | 51,037 | $2,858,000 | 1.50% |